UC Davis Medical Center researchers have recently been awarded several grants to investigate promising treatments for Angleman Syndrome. Dr. David Segal, professor in the Department of Biochemistry and Molecular Medicine, has received over $1.2 million from the Foundation for Angelman Syndrome Therapeutics (FAST) to develop a potential treatment. Joe Anderson, PhD, assistant adjunct professor in the Department of Internal Medicine, received $500,000 from the same organization to pursue a different approach to developing a treatment for the genetic disorder. The university also received a $1.1 million grant from the California Institute for Regenerative Medicine (CIRM) in July, which brings the total for Angelman Syndrome grant funding to nearly $3 million. This puts UC Davis at the forefront of research into the disorder.
(Image of UBE3A Protien courtesy of Wikimedia Commons)Read More